LOPIGIM®600

Composition: Each tablet contains:
Gemfibrozil. . . . . . . . . . . . . . . . . . . . . . . 600 mg
Presentation:
Box of 3 blisters x 10 tablets.
Indications:
Gemfibrozil is a lipid regulating agent, which is indicated for the following cases:
Primary prevention of coronary heart disease (CHD) and myocardial infarction (MI) in patients with hypercholesterolaemia, mixed dyslipidemia and hypertriglyceridemia, types IIa, IIb and IV according to the Fredrickson classification.
Treatment of other dyslipidemia:
– Dyslipidemia type III and type V according to the Fredrickson classification.
– Dyslipidemia in patients with diabetes mellitus.
– Dyslipidemia in patients with xanthoma.
Treatment of adult patients with very high elevations of serum triglyceride levels (Types IV and V hyperlipidemia), who present a risk of pancreatitis and who do not respond adequately to a determined dietary effort to control them.

LIÊN HỆ MUA HÀNG HOẶC CẦN TƯ VẤN

error: Không được phép!